317 related articles for article (PubMed ID: 34494089)
41. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
43. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
46. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.
Ouyang H; Gore J; Deitz S; Korc M
Oncogene; 2014 Sep; 33(38):4664-74. PubMed ID: 24096486
[TBL] [Abstract][Full Text] [Related]
47. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
49. The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target.
Vosgha H; Salajegheh A; Smith RA; Lam AK
Curr Cancer Drug Targets; 2014; 14(7):621-37. PubMed ID: 25308719
[TBL] [Abstract][Full Text] [Related]
50. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
51. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
52. miR-197: A novel biomarker for cancers.
Wang DD; Chen X; Yu DD; Yang SJ; Shen HY; Sha HH; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Oct; 591(2):313-9. PubMed ID: 27320730
[TBL] [Abstract][Full Text] [Related]
53. miR-655: A promising regulator with therapeutic potential.
Li H; Zhang J; Yang Y; Duan S
Gene; 2020 Oct; 757():144932. PubMed ID: 32640310
[TBL] [Abstract][Full Text] [Related]
54. The miR-15a/16 gene cluster in human cancer: A systematic review.
Liu T; Xu Z; Ou D; Liu J; Zhang J
J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332
[TBL] [Abstract][Full Text] [Related]
55. Molecular Mechanisms of miR-214 Involved in Cancer and Drug Resistance.
Karimi E; Dehghani A; Azari H; Zarei M; Shekari M; Mousavi P
Curr Mol Med; 2023 May; 23(7):589-605. PubMed ID: 37282586
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin.
Su J; Zhang A; Shi Z; Ma F; Pu P; Wang T; Zhang J; Kang C; Zhang Q
Int J Oncol; 2012 Apr; 40(4):1162-70. PubMed ID: 22211245
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt/β-catenin pathway.
Xie C; Wu Y; Fei Z; Fang Y; Xiao S; Su H
J Cell Mol Med; 2020 Jan; 24(1):747-759. PubMed ID: 31733028
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAF
Yan R; Yang T; Zhai H; Zhou Z; Gao L; Li Y
J Cell Biochem; 2018 Nov; 119(11):8763-8772. PubMed ID: 30126001
[TBL] [Abstract][Full Text] [Related]
59. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
[TBL] [Abstract][Full Text] [Related]
60. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]